Ambulatory blood pressure, left ventricular mass and vascular phenotypes in relation to the endothelial nitric oxide synthase gene Glu298Asp and intron 4 polymorphisms in a population-based family study.
Reduced nitric oxide production is associated with pathological changes in the cardiovascular system. In a study of randomly chosen families, we analysed the relationship between two polymorphisms (Glu298Asp and intron 4) of the endothelial nitric oxide synthase (eNOS) and ambulatory blood pressure (ABP), left ventricular mass index (LVMI) and vascular phenotypes. The study population consisted of 127 parents and 167 offspring. All subjects underwent 24 h ABP monitoring using a SpaceLabs 90207 device. 2D and M-mode echocardiograms were obtained. Pulse wave velocity between the common carotid and femoral artery was measured with the Complior device, and the carotid intima-media thickness (IMT) was assessed by ultrasound. For statistical analysis, covariables and correlations between relatives were taken into account. The frequency of genotypes was as follows: for Glu298Asp: 55.1%-Glu/Glu, 40.1%-Glu/Asp and 4.8%-Asp/Asp; for intron 4: 65.0%-4 b/b, 33.3%-4 b/a and 1.7%-4 a/a, being in Hardy-Weinberg equilibrium (P > or = 0.29). There was no relationship between the eNOS gene polymorphisms and ABP or LVMI either in parents or their offspring. Among parents, carriers of the 298Asp allele had higher IMT values as compared with Glu/Glu homozygotes (0.94 vs 0.70 mm; P = 0.007). Among offspring, there was a similar tendency (0.60 vs 0.53 mm; P = 0.10), which was confirmed by transmission disequilibrium tests for quantitative variables (P > or = 0.07). Our findings indicate that the Glu298Asp polymorphism of eNOS identifies patients with larger carotid IMT, also in younger subjects.
Czarnecka
D
D
First Cardiac Department, Medical College, Jagiellonian University, Cracow, Poland. dczarnecka@interia.pl
Kawecka-Jaszcz
K
K
Stolarz
K
K
Olszanecka
A
A
Dembińska-Kieć
A
A
Kieć-Wilk
B
B
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000483:Alleles; D001161:Arteriosclerosis / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*; D001794:Blood Pressure / Q000235:genetics*; D018660:Blood Pressure Monitoring, Ambulatory; D017536:Carotid Artery, Common / Q000000981:diagnostic imaging / Q000503:physiopathology; D002940:Circadian Rhythm / Q000502:physiology; D004452:Echocardiography; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging / Q000503:physiopathology; D005787:Gene Frequency; D005838:Genotype; D006352:Heart Ventricles / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D007438:Introns / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000097:blood / Q000235:genetics*; D052250:Nitric Oxide Synthase Type III; D009679:Nuclear Family; D011044:Poland / Q000453:epidemiology; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011159:Population Surveillance; D015995:Prevalence; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016277:Ventricular Function, Left / Q000502:physiology*
C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III
J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
2698218
Circulation. 1996 Sep 15;94(6):1298-303
8822983
Ann Hum Genet. 1999 Jul;63(Pt 4):329-40
10738544
Circulation. 2001 Jul 24;104(4):448-54
11468208
Arterioscler Thromb. 1994 May;14(5):753-9
7513551
Circ Res. 2002 Jun 14;90(11):1153-8
12065317
Circulation. 1978 Dec;58(6):1072-83
709763
Circulation. 2001 Jul 17;104(3):342-5
11457755
Blood Press Monit. 2002 Aug;7(4):215-24
12198337
Hypertension. 1999 Apr;33(4):924-6
10205224
Circulation. 1999 Jun 22;99(24):3096-8
10377070
Am J Hypertens. 2000 Sep;13(9):994-8
10981549
West J Med. 1996 May;164(5):419-24
8686299
J Am Coll Cardiol. 1998 Jun;31(7):1506-10
9626827
Arterioscler Thromb. 1993 Oct;13(10):1404-11
8399076
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2832-5
10717002
Eur J Hum Genet. 2000 Jul;8(7):545-51
10909856
N Engl J Med. 1999 Jan 14;340(2):115-26
9887164
Am J Med Genet. 2001 Apr 22;100(2):130-7
11298374
Stroke. 1998 Sep;29(9):1908-11
9731617
Nat Med. 1996 Jan;2(1):41-5
8564837
Clin Nephrol. 1999 Oct;52(4):203-9
10543322
Stroke. 2001 Mar;32(3):735-40
11239195
Ann Intern Med. 1998 Feb 15;128(4):262-9
9471928
Eur J Clin Invest. 2003 Mar;33(3):191-8
12641536
Am J Kidney Dis. 2003 Apr;41(4):822-32
12666069
Circulation. 1998 Jun 30;97(25):2494-8
9657467
Am J Hypertens. 1998 Jan;11(1 Pt 1):125-8
9504461
J Clin Invest. 1998 Feb 15;101(4):731-6
9466966
J Hypertens. 1998 Jan;16(1):31-5
9533414
Am J Hum Genet. 1997 Mar;60(3):676-90
9042929
Biochem Biophys Res Commun. 1998 Apr 7;245(1):190-3
9535806
Lancet. 1997 Mar 22;349(9055):837-42
9121259
Am J Hum Genet. 2000 Jan;66(1):279-92
10631157
J Mol Med (Berl). 2000;78(7):372-9
11043380
J Hypertens. 2001 Nov;19(11):1941-8
11677358
N Engl J Med. 1993 Dec 30;329(27):2002-12
7504210
J Intern Med. 2002 Feb;251(2):102-10
11905585
Circulation. 1997 Sep 2;96(5):1432-7
9315528
Am J Hypertens. 1994 Aug;7(8):685-94
7986458
Am J Cardiol. 1986 Feb 15;57(6):450-8
2936235
Lancet. 1989 Oct 28;2(8670):997-1000
2572793
Nature. 1993 Apr 29;362(6423):801-9
8479518
J Hypertens. 1995 Sep;13(9):1053-8
8586824
Nature. 1995 Sep 21;377(6546):239-42
7545787